Skip to main content
MedPathMedPath Home
Clinical Trials/EUCTR2004-002312-29-IT
EUCTR2004-002312-29-IT
Active, not recruiting
Not Applicable

The Effects of Nitric Oxide for Inhalation on the Development of Chronic Lung Disease in Pre-term Infants

INO THERAPEUTICS0 sitesMarch 23, 2007
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsPrevention of chronic lung disease in pre-term infants gestational age 29 weeks with respiratory distress.MedDRA version: 9.1Level: LLTClassification code 10028974Term: Neonatal respiratory distress syndrome
DrugsINOMAX BOMB 10L 400PPM MOL/MOL

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Prevention of chronic lung disease in pre-term infants gestational age 29 weeks with respiratory distress.
Sponsor
INO THERAPEUTICS
Status
Active, not recruiting
Last Updated
10 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
March 23, 2007
End Date
TBD
Last Updated
10 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Sponsor
INO THERAPEUTICS

Eligibility Criteria

Inclusion Criteria

  • •Are the trial subjects under 18? yes
  • •Number of subjects for this age range:
  • •F.1\.2 Adults (18\-64 years) no
  • •F.1\.2\.1 Number of subjects for this age range
  • •F.1\.3 Elderly (\>\=65 years) no
  • •F.1\.3\.1 Number of subjects for this age range

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Similar Trials

Active, not recruiting
Not Applicable
The Effects of Nitric Oxide for Inhalation on the Development of Chronic Lung Disease in Pre-term Infants.
EUCTR2004-002312-29-DEINO Therapeutics800
Active, not recruiting
Phase 1
The Effects of Nitric Oxide for Inhalation on the development of chronic lung disease in pre-term infants. - INOT-27Prevention of chronic lung disease in pre-term infants ( gestational age < 29 weeks) with respiratory distress.MedDRA version: 7.0 Level: LLT Classification code 10054933
EUCTR2004-002312-29-GBINO Therapeutics800
Active, not recruiting
Phase 1
The Effects of Nitric Oxide for Inhalation on the development of chronic lung disease in pre-term infants. - INOT-27Prevention of chronic lung disease in pre-term infants ( gestational age < 29 weeks) with respiratory distress.MedDRA version: 7.0Level: LLTClassification code 10054933
EUCTR2004-002312-29-FIINO Therapeutics800
Active, not recruiting
Not Applicable
The Effects of Nitric Oxide for Inhalation on the development of chronic lung disease in pre-term infants. - INOT-27
EUCTR2004-002312-29-ESINO Therapeutics600
Active, not recruiting
Not Applicable
The Effects of Nitric Oxide for Inhalation on the development of chronic lung disease in pre-term infants. - INOT-27
EUCTR2004-002312-29-SEINO Therapeutics800